BioCentury
ARTICLE | Company News

Acambis, Arrow Therapeutics plc deal

June 16, 2003 7:00 AM UTC

Arrow and ACAM will use Arrow's Transposon Mediated Differential Hybridization (TMDH) technology to develop an attenuated or subunit vaccine against an undisclosed antigen chosen by ACAM. The technolo...